996 related articles for article (PubMed ID: 28297624)
41. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C
Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988
[TBL] [Abstract][Full Text] [Related]
42. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
[TBL] [Abstract][Full Text] [Related]
43. [Current diagnosis and treatment for pediatric acute myeloid leukemia].
Shiba N
Rinsho Ketsueki; 2017; 58(4):389-399. PubMed ID: 28484171
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive molecular understanding of pediatric acute myeloid leukemia.
Shiba N
Int J Hematol; 2023 Feb; 117(2):173-181. PubMed ID: 36653696
[TBL] [Abstract][Full Text] [Related]
45. Translational implications of somatic genomics in acute myeloid leukaemia.
Meyer SC; Levine RL
Lancet Oncol; 2014 Aug; 15(9):e382-94. PubMed ID: 25079101
[TBL] [Abstract][Full Text] [Related]
46. Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectives.
Thol F; Ganser A
Front Med China; 2010 Dec; 4(4):356-62. PubMed ID: 21125345
[TBL] [Abstract][Full Text] [Related]
47. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
48. Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia.
Berenstein R; Blau IW; Suckert N; Baldus C; Pezzutto A; Dörken B; Blau O
J Exp Clin Cancer Res; 2015 May; 34(1):55. PubMed ID: 25994761
[TBL] [Abstract][Full Text] [Related]
49. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
50. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
Ahn JS; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Biol Blood Marrow Transplant; 2016 Jan; 22(1):61-70. PubMed ID: 26234722
[TBL] [Abstract][Full Text] [Related]
51. Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.
Marjanovic I; Kostic J; Stanic B; Pejanovic N; Lucic B; Karan-Djurasevic T; Janic D; Dokmanovic L; Jankovic S; Vukovic NS; Tomin D; Perisic O; Rakocevic G; Popovic M; Pavlovic S; Tosic N
Tumour Biol; 2016 Oct; 37(10):13391-13401. PubMed ID: 27460089
[TBL] [Abstract][Full Text] [Related]
52. Current status and trends in the diagnostics of AML and MDS.
Shumilov E; Flach J; Kohlmann A; Banz Y; Bonadies N; Fiedler M; Pabst T; Bacher U
Blood Rev; 2018 Nov; 32(6):508-519. PubMed ID: 29728319
[TBL] [Abstract][Full Text] [Related]
53. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia.
Abdel-Wahab O; Levine RL
Blood; 2013 May; 121(18):3563-72. PubMed ID: 23640996
[TBL] [Abstract][Full Text] [Related]
54. Current findings for recurring mutations in acute myeloid leukemia.
Takahashi S
J Hematol Oncol; 2011 Sep; 4():36. PubMed ID: 21917154
[TBL] [Abstract][Full Text] [Related]
55. When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
Roloff GW; Griffiths EA
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):35-44. PubMed ID: 30504289
[TBL] [Abstract][Full Text] [Related]
56. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
[TBL] [Abstract][Full Text] [Related]
57. Mutation position within evolutionary subclonal architecture in AML.
Welch JS
Semin Hematol; 2014 Oct; 51(4):273-81. PubMed ID: 25311740
[TBL] [Abstract][Full Text] [Related]
58. Mutations in AML: prognostic and therapeutic implications.
DiNardo CD; Cortes JE
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):348-355. PubMed ID: 27913501
[TBL] [Abstract][Full Text] [Related]
59. Recent discoveries in molecular characterization of acute myeloid leukemia.
Khasawneh MK; Abdel-Wahab O
Curr Hematol Malig Rep; 2014 Jun; 9(2):93-9. PubMed ID: 24609756
[TBL] [Abstract][Full Text] [Related]
60. [Precision medicine for acute myeloid leukemia based on genomic profiling].
Sanada M
Rinsho Ketsueki; 2019; 60(7):847-853. PubMed ID: 31391376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
